These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16789430)

  • 1. Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation.
    Bustanji Y; Taha MO; Yousef AM; Al-Bakri AG
    J Enzyme Inhib Med Chem; 2006 Apr; 21(2):163-71. PubMed ID: 16789430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine.
    Al-masri IM; Mohammad MK; Tahaa MO
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1061-6. PubMed ID: 19640223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Apr; 10(4):897-906. PubMed ID: 11836096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B.
    Bustanji Y; Taha MO; Al-Masri IM; Mohammad MK
    Biol Pharm Bull; 2009 Apr; 32(4):640-5. PubMed ID: 19336898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Jul; 10(7):2267-82. PubMed ID: 11983524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine phosphatase 1B in hematopoiesis.
    Heinonen KM; Tremblay ML
    Cell Cycle; 2006 May; 5(10):1053-6. PubMed ID: 16687929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization and crystal structure of the C215D mutant of protein-tyrosine phosphatase-1B.
    Romsicki Y; Scapin G; Beaulieu-Audy V; Patel S; Becker JW; Kennedy BP; Asante-Appiah E
    J Biol Chem; 2003 Aug; 278(31):29009-15. PubMed ID: 12748196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent.
    Cheon HG; Kim SM; Yang SD; Ha JD; Choi JK
    Eur J Pharmacol; 2004 Feb; 485(1-3):333-9. PubMed ID: 14757158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
    Malla P; Kumar R; Kumar M
    Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
    Ramírez-Espinosa JJ; Rios MY; López-Martínez S; López-Vallejo F; Medina-Franco JL; Paoli P; Camici G; Navarrete-Vázquez G; Ortiz-Andrade R; Estrada-Soto S
    Eur J Med Chem; 2011 Jun; 46(6):2243-51. PubMed ID: 21453996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic acid derivatives as potential antidiabetic agents: In vitro, in vivo, and in silico studies.
    Guzmán-Ávila R; Flores-Morales V; Paoli P; Camici G; Ramírez-Espinosa JJ; Cerón-Romero L; Navarrete-Vázquez G; Hidalgo-Figueroa S; Yolanda Rios M; Villalobos-Molina R; Estrada-Soto S
    Drug Dev Res; 2018 Mar; 79(2):70-80. PubMed ID: 29380400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.
    Mohammad MK; Al-Masri IM; Taha MO; Al-Ghussein MA; Alkhatib HS; Najjar S; Bustanji Y
    Eur J Pharmacol; 2008 Apr; 584(1):185-91. PubMed ID: 18295757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
    Cerón-Romero L; Paoli P; Camici G; Flores-Morales V; Rios MY; Ramírez-Espinosa JJ; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2018-22. PubMed ID: 26961283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
    J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.